TY - JOUR
T1 - Septal myectomy after failed alcohol ablation
T2 - Does previous percutaneous intervention compromise outcomes of myectomy?
AU - Quintana, Eduard
AU - Sabate-Rotes, Anna
AU - Maleszewski, Joseph J.
AU - Ommen, Steve R.
AU - Nishimura, Rick A.
AU - Dearani, Joseph A.
AU - Schaff, Hartzell V.
N1 - Funding Information:
AS-R was supported by Fundació La Caixa , Barcelona, Spain.
Publisher Copyright:
© 2015 The American Association for Thoracic Surgery.
PY - 2015
Y1 - 2015
N2 - Objective The impact of prior alcohol septal ablation in patients who require septal myectomy for hypertrophic obstructive cardiomyopathy is unknown. Methods Thirty-one patients with unsuccessful alcohol septal ablation who underwent septal myectomy were matched 1:2 to patients having had a myectomy as the only invasive procedure for hypertrophic obstructive cardiomyopathy. Study outcomes were cardiac death, advanced heart failure, and appropriate implantable cardioverter defibrillator discharge. The results of surgery, echocardiograms, and pathology specimens were compared between groups. Results Patients with previous alcohol septal ablation had increased diastolic dysfunction in preoperative echocardiography, as well as more implantable cardioverter defibrillators implanted (32% vs 11%, P =.01), more arrhythmias in preoperative Holter monitoring (43% vs 13%, P =.02), and a higher incidence of postoperative complete heart block (19.4% vs 1.6%, P <.01). Two patients died early postoperatively in the prior alcohol septal ablation group, and no patients died in the primary myectomy group. One patient in each group had an implantable cardioverter defibrillator (P =.52). At a mean follow-up of 3.2 years, 7 of 31 patients and 6 of 62 patients progressed to advanced heart failure in the prior alcohol septal ablation group and the primary myectomy group, respectively (P =.1) Histopathologic analysis demonstrated greater interstitial (70% vs 26%, P <.01) and endocardial fibrosis (87% vs 67%, P =.04) in the alcohol septal ablation group. Conclusions Patients with prior alcohol septal ablation undergoing surgical septal myectomy may have an increased risk of cardiac death, advanced heart failure, and implantable cardioverter defibrillator discharges. This supports septal myectomy as the preferred treatment for septal reduction therapy, avoiding scarring and diastolic dysfunction inherent to alcohol septal ablation.
AB - Objective The impact of prior alcohol septal ablation in patients who require septal myectomy for hypertrophic obstructive cardiomyopathy is unknown. Methods Thirty-one patients with unsuccessful alcohol septal ablation who underwent septal myectomy were matched 1:2 to patients having had a myectomy as the only invasive procedure for hypertrophic obstructive cardiomyopathy. Study outcomes were cardiac death, advanced heart failure, and appropriate implantable cardioverter defibrillator discharge. The results of surgery, echocardiograms, and pathology specimens were compared between groups. Results Patients with previous alcohol septal ablation had increased diastolic dysfunction in preoperative echocardiography, as well as more implantable cardioverter defibrillators implanted (32% vs 11%, P =.01), more arrhythmias in preoperative Holter monitoring (43% vs 13%, P =.02), and a higher incidence of postoperative complete heart block (19.4% vs 1.6%, P <.01). Two patients died early postoperatively in the prior alcohol septal ablation group, and no patients died in the primary myectomy group. One patient in each group had an implantable cardioverter defibrillator (P =.52). At a mean follow-up of 3.2 years, 7 of 31 patients and 6 of 62 patients progressed to advanced heart failure in the prior alcohol septal ablation group and the primary myectomy group, respectively (P =.1) Histopathologic analysis demonstrated greater interstitial (70% vs 26%, P <.01) and endocardial fibrosis (87% vs 67%, P =.04) in the alcohol septal ablation group. Conclusions Patients with prior alcohol septal ablation undergoing surgical septal myectomy may have an increased risk of cardiac death, advanced heart failure, and implantable cardioverter defibrillator discharges. This supports septal myectomy as the preferred treatment for septal reduction therapy, avoiding scarring and diastolic dysfunction inherent to alcohol septal ablation.
KW - Key Words Hypertrophic obstructive cardiomyopathy
KW - septal alcohol ablation
KW - septal myectomy
UR - http://www.scopus.com/inward/record.url?scp=84941104892&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84941104892&partnerID=8YFLogxK
U2 - 10.1016/j.jtcvs.2015.03.044
DO - 10.1016/j.jtcvs.2015.03.044
M3 - Article
C2 - 25940414
AN - SCOPUS:84941104892
SN - 0022-5223
VL - 150
SP - 159-167.e1
JO - Journal of Thoracic and Cardiovascular Surgery
JF - Journal of Thoracic and Cardiovascular Surgery
IS - 1
ER -